October 20th 2025
* Generic lenacapavir could be produced for $25 per person per year at scale, according to an analysis presented at IDWeek 2025 in Atlanta.
Identification of children at high-risk for MIS-C
July 17th 2020Every pediatric provider including pediatric nurse practitioners and pediatric nurses working in hospital or in outpatient settings must know the various ways children and adolescents may present with possible COVID-19 symptoms. They must also know which patients are at high risk of developing multisystem inflammatory syndrome in children (MIS-C).
Zika may have led to negative outcomes in kids born with normal head size
July 16th 2020Parents of newborns who had been exposed to Zika virus in utero may have breathed a sigh of relief when their child was born with normocephaly. An investigation finds that adverse outcomes occurred even in children with normal head size.
Multisystem inflammatory syndrome in children associated with COVID-19
July 13th 2020Children who at first did not appear to contract COVID-19 have been found to exhibit a more serious illness that has now been reported worldwide. Two experts offer guidance on recognizing and treating multisystem inflammatory syndrome in children (MIS-C).
Using an improvement program to improve Chlamydia trachomatis testing
July 8th 2020Clinicians may still use urine nucleic-acid amplification tests, despite the recommendation to use a more sensitive vaginal swab to test for Chlamydia trachomatis. A report looks at whether a quality improvement program could change that.
Italian study offers more information on how MIS-C differs from Kawasaki disease
June 16th 2020Since late April, more and more cases of multisystem inflammatory syndrome in children (MIS-C) have been found around the United States. A report from Italy provides more information on how it differs from Kawasaki disease.